查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600173

骨生技药品市场：按产品、技术、加工方法、饲料材料、应用和最终用户 - 2025-2030 年全球预测

Osteobiologics Market by Product, Technique, Processing Method, Material Sourced, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年骨生技药品市场价值为12.9亿美元，预计到2024年将达到13.6亿美元，复合年增长率为5.47%，到2030年将达到18.8亿美元。

骨生技药品是更广泛的生物材料市场的一个子集，包括促进骨癒合、再生和修復的产品。其中包括移植骨替代物、生长因子和细胞支架，它们在整形外科和牙科手术中发挥重要作用。骨质疏鬆症和骨关节炎等骨疾病盛行率的上升、人口老化以及外科手术的进步推动了对骨生技药品的需求。主要应用包括脊椎融合手术、创伤融合术和自然癒合不足的重组手术。医院、专科诊所和研究机构是骨生技药品产品的主要最终使用者。关键的市场开拓因素包括材料科学和生物工程的技术进步、研发投资的增加以及对微创手术技术的日益关注。更接近天然骨特性的合成骨移植物的开发以及定制植入3D 列印技术的创新正在带来机会。建议包括专注于开发强大的产品平臺来满足未满足的临床需求，并寻求与医疗机构的策略伙伴关係以提高市场渗透率。然而，骨生技药品的高成本、严格的法律规范以及免疫反应和排斥风险等挑战限制了市场的成长。此外，与产品标准化相关的复杂性和漫长的核准时间阻碍了快速创新。为了克服这些障碍，公司应该投资于具有成本效益的製造技术并参与协作研发以简化监管核准。这个市场竞争激烈，注重科学进步，并提高消费者对骨生技药品益处的认识。结合生物和合成成分以产生卓越效果的生物活性材料和混合用途疗法具有相当大的创新空间，并为市场扩张和差异化提供了利润丰厚的途径。

主要市场统计
基准年[2023] 12.9亿美元
预测年份 [2024] 13.6亿美元
预测年份 [2030] 18.8亿美元
复合年增长率（%） 5.47%

市场动态：揭示快速发展的骨生技药品市场的关键市场洞察

供需的动态交互作用正在改变骨生技药品市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 全球老化人口不断增加，骨骼相关疾病盛行率上升
    • 涉及骨骼和关节的外科手术需要先进的骨癒合解决方案的增加
    • 对微创治疗的需求不断增长
  • 市场限制因素
    • 临床结果的变异性影响产品的可靠性和可接受性
  • 市场机会
    • 使用 3D 列印和组织工程开发针对患者的治疗方法
    • 扩大产品线，纳入新型材料和生物药品组合，以提高功效
  • 市场问题
    • 意识淡薄，缺乏熟练的专业人员

波特五力：驾驭骨生技药品市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解骨生技药品市场的外部影响

外部宏观环境因素在塑造骨生技药品市场的表现动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解骨生技药品市场的竞争格局

对骨生技药品市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的见解，以应对日益激烈的竞争。

FPNV 定位矩阵：骨生技药品市场供应商的绩效评估

FPNV定位矩阵是评估骨生技药品市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製骨生技药品市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对骨生技药品市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 随着全球人口持续老化，骨骼相关疾病的发生率也上升。
      • 涉及骨骼和关节的外科手术正在增加，这产生了对先进骨癒合解决方案的需求
      • 对微创治疗的需求不断增长
    • 抑制因素
      • 影响产品可靠性和可接受性的临床结果的变异性
    • 机会
      • 使用 3D 列印和组织工程开发针对患者的治疗方法
      • 扩大产品线，包括新材料和生物药品的组合，以提高功效
    • 任务
      • 意识淡薄，缺乏熟练的专业人员
  • 市场区隔分析
    • 产品：由于支持新骨生长的骨传导特性，同种异体移植物的新用途
    • 应用：需要结合抗菌和再生特性来靶向骨感染疾病和肿瘤的骨生物解决方案
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章骨生技药品市场：副产品

  • 介绍
  • 同种异体移植
  • 骨髓抽吸浓缩液
  • 骨形成蛋白
  • 去矿物质骨基质
  • 血浆蛋白
  • 生物性骨材
  • 黏性补充品产品

第七章骨生技药品市场：依技术分类

  • 介绍
  • 生物陶瓷及复合材料
  • 可注射生物材料
  • 整形外科生物材料植入

第八章骨生技药品市场：依加工方法分类

  • 介绍
  • 海水淡化
  • 矿化作用
  • 骨传导性
  • 骨诱导

第九章骨生技药品市场：依供应材料分类

  • 介绍
  • 自然的
  • 合成

第10章骨生技药品市场：依应用分类

  • 介绍
  • 骨感染疾病和肿瘤
  • 牙科骨移植
  • 关节重组
  • 脊椎融合手术
  • 外伤和不癒合骨折

第十一章骨骼生技药品市场：依最终用户分类

  • 介绍
  • 医院
  • 研究/学术机构
  • 专科诊所

第十二章美洲生技药品市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十三章亚太骨生技药品市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十四章欧洲、中东和非洲的骨生技药品市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Biogennix 推出由牛胶原蛋白製成的 Agilon 手术基质
    • Biogennix 的 Agilon 和 Morpheus Small Double 产品已获得 FDA 批准
    • 位于尔湾的 Biogenics 推出骨跨纤维基质以改善手术效果
  • 战略分析和建议

公司名单

  • Advancells Diagnostics
  • Aetna Inc.
  • AlloSource
  • Anika Therapeutics, Inc.
  • Arthrex, Inc.
  • Australian BIoTechnologies Pty Ltd
  • Baxter International Inc.
  • Biogennix, LLC.
  • CONMED Corporation
  • Exactech, Inc.（TPG Capital 为母公司）
  • Geistlich Pharma AG
  • Integra LifeSciences Holdings Corporation
  • KLS Martin Group
  • KNITPRO INTERNATIONAL
  • Medical Device Business Services, Inc.
  • Medtronic Plc
  • MTF Biologics
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • Osiris Therapeutics, Inc.（被 Smith & Nephew 收购）
  • ROYAL BIOLOGICS
  • RTI Surgical Holdings, Inc.（被 Montagu Private Equity LLP 收购）
  • Stryker Corporation
  • SynerHeal Pharmaceuticals
  • Wright Medical Group NV
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-036C5CF3B4C0

The Osteobiologics Market was valued at USD 1.29 billion in 2023, expected to reach USD 1.36 billion in 2024, and is projected to grow at a CAGR of 5.47%, to USD 1.88 billion by 2030.

Osteobiologics, a subset of the broader biomaterials market, encompass products that promote bone healing, regeneration, and repair. These include bone graft substitutes, growth factors, and cellular scaffolds, playing crucial roles in orthopedic and dental surgeries. The demand for osteobiologics is driven by the rising prevalence of bone disorders such as osteoporosis and osteoarthritis, the growing aging population, and advancements in surgical procedures. Key applications lie in spinal fusion, trauma fixation, and reconstructive surgeries where natural bone healing is insufficient. Hospitals, specialized clinics, and research institutions comprise the primary end-users of osteobiologics products. Significant market growth factors include technological advancements in material science and bioengineering, increased investment in research and development, and a rising focus on minimally invasive surgical techniques. Opportunities are emerging from developing synthetic bone grafts that mimic natural bone properties more closely and innovations in 3D printing technology for customized implants. Recommendations include focusing on robust product pipeline development to address unmet clinical needs and pursuing strategic partnerships with healthcare institutions for enhanced market penetration. However, challenges such as the high cost of osteobiologic products, stringent regulatory frameworks, and the risk of immune response or rejection limit market growth. Furthermore, complexities related to product standardization and long approval timelines impede rapid innovation. To overcome these barriers, companies should invest in cost-effective manufacturing technologies and engage in collaborative R&D to streamline regulatory approvals. The nature of this market is highly competitive, with a strong emphasis on scientific advancement and increased consumer awareness about the benefits of osteobiologics. There is considerable scope for innovation in bioactive materials and mixed-use therapies combining biological and synthetic components for superior outcomes, presenting lucrative avenues for market expansion and differentiation.

KEY MARKET STATISTICS
Base Year [2023] USD 1.29 billion
Estimated Year [2024] USD 1.36 billion
Forecast Year [2030] USD 1.88 billion
CAGR (%) 5.47%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Osteobiologics Market

The Osteobiologics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing aging population globally and rising prevalence of bone-related conditions
    • Rising surgical interventions involving bones and joints necessitating advanced bone healing solutions
    • Growing demand for minimally invasive treatments
  • Market Restraints
    • Variability in clinical outcomes affecting the credibility and acceptance of products
  • Market Opportunities
    • Development of patient-specific treatments using 3D printing and tissue engineering
    • Expansion of product lines to include novel materials and combinations of biological agents for enhanced efficacy
  • Market Challenges
    • Limited awareness and dearth of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Osteobiologics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Osteobiologics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Osteobiologics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Osteobiologics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Osteobiologics Market

A detailed market share analysis in the Osteobiologics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Osteobiologics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Osteobiologics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Osteobiologics Market

A strategic analysis of the Osteobiologics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Osteobiologics Market, highlighting leading vendors and their innovative profiles. These include Advancells Diagnostics, Aetna Inc., AlloSource, Anika Therapeutics, Inc., Arthrex, Inc., Australian Biotechnologies Pty Ltd, Baxter International Inc., Biogennix, LLC., CONMED Corporation, Exactech, Inc.(parent company TPG Capital), Geistlich Pharma AG, Integra LifeSciences Holdings Corporation, KLS Martin Group, KNITPRO INTERNATIONAL, Medical Device Business Services, Inc., Medtronic Plc, MTF Biologics, NuVasive, Inc., Orthofix Medical Inc., Osiris Therapeutics, Inc. (acquired by Smith & Nephew), ROYAL BIOLOGICS, RTI Surgical Holdings, Inc.(acquired by Montagu Private Equity LLP), Stryker Corporation, SynerHeal Pharmaceuticals, Wright Medical Group N.V., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Osteobiologics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Allografts, Bone Marrow Aspirate Concentrate, Bone Morphogenic Protein, Demineralized Bone Matrices, Plasma-Rich Protein, Synthetic Orthobiologics, and Visco-Supplementation Products.
  • Based on Technique, market is studied across Bioceramics & Composites, Injectable Biomaterials, and Orthopedic Biomaterial Implants.
  • Based on Processing Method, market is studied across Demineralized, Mineralized, Osteoconductive, and Osteoinductive.
  • Based on Material Sourced, market is studied across Natural and Synthetic.
  • Based on Application, market is studied across Bone Infection & Tumors, Dental Bone Grafting, Joint Reconstruction, Spinal Fusion, and Trauma & Non-Union Fractures.
  • Based on End-User, market is studied across Hospitals, Research & Academic Institutes, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing aging population globally and rising prevalence of bone-related conditions
      • 5.1.1.2. Rising surgical interventions involving bones and joints necessitating advanced bone healing solutions
      • 5.1.1.3. Growing demand for minimally invasive treatments
    • 5.1.2. Restraints
      • 5.1.2.1. Variability in clinical outcomes affecting the credibility and acceptance of products
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of patient-specific treatments using 3D printing and tissue engineering
      • 5.1.3.2. Expansion of product lines to include novel materials and combinations of biological agents for enhanced efficacy
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness and dearth of skilled professionals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Emerging usage of allografts owing to their osteoconductive properties that support new bone growth
    • 5.2.2. Application: Need for osteobiologic solutions that combine antimicrobial and regenerative properties for targeting bone infection & tumors
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Osteobiologics Market, by Product

  • 6.1. Introduction
  • 6.2. Allografts
  • 6.3. Bone Marrow Aspirate Concentrate
  • 6.4. Bone Morphogenic Protein
  • 6.5. Demineralized Bone Matrices
  • 6.6. Plasma-Rich Protein
  • 6.7. Synthetic Orthobiologics
  • 6.8. Visco-Supplementation Products

7. Osteobiologics Market, by Technique

  • 7.1. Introduction
  • 7.2. Bioceramics & Composites
  • 7.3. Injectable Biomaterials
  • 7.4. Orthopedic Biomaterial Implants

8. Osteobiologics Market, by Processing Method

  • 8.1. Introduction
  • 8.2. Demineralized
  • 8.3. Mineralized
  • 8.4. Osteoconductive
  • 8.5. Osteoinductive

9. Osteobiologics Market, by Material Sourced

  • 9.1. Introduction
  • 9.2. Natural
  • 9.3. Synthetic

10. Osteobiologics Market, by Application

  • 10.1. Introduction
  • 10.2. Bone Infection & Tumors
  • 10.3. Dental Bone Grafting
  • 10.4. Joint Reconstruction
  • 10.5. Spinal Fusion
  • 10.6. Trauma & Non-Union Fractures

11. Osteobiologics Market, by End-User

  • 11.1. Introduction
  • 11.2. Hospitals
  • 11.3. Research & Academic Institutes
  • 11.4. Specialty Clinics

12. Americas Osteobiologics Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Osteobiologics Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Osteobiologics Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Biogennix launches Agilon Surgical Matrix made from bovine collagen
    • 15.3.2. Biogennix receives FDA clearance for Agilon and Morpheus Moldable products
    • 15.3.3. Irvine-based biogennix launches osteospan fiber matrix to enhance surgical outcomes
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advancells Diagnostics
  • 2. Aetna Inc.
  • 3. AlloSource
  • 4. Anika Therapeutics, Inc.
  • 5. Arthrex, Inc.
  • 6. Australian Biotechnologies Pty Ltd
  • 7. Baxter International Inc.
  • 8. Biogennix, LLC.
  • 9. CONMED Corporation
  • 10. Exactech, Inc.(parent company TPG Capital)
  • 11. Geistlich Pharma AG
  • 12. Integra LifeSciences Holdings Corporation
  • 13. KLS Martin Group
  • 14. KNITPRO INTERNATIONAL
  • 15. Medical Device Business Services, Inc.
  • 16. Medtronic Plc
  • 17. MTF Biologics
  • 18. NuVasive, Inc.
  • 19. Orthofix Medical Inc.
  • 20. Osiris Therapeutics, Inc. (acquired by Smith & Nephew)
  • 21. ROYAL BIOLOGICS
  • 22. RTI Surgical Holdings, Inc.(acquired by Montagu Private Equity LLP)
  • 23. Stryker Corporation
  • 24. SynerHeal Pharmaceuticals
  • 25. Wright Medical Group N.V.
  • 26. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. OSTEOBIOLOGICS MARKET RESEARCH PROCESS
  • FIGURE 2. OSTEOBIOLOGICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL OSTEOBIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. OSTEOBIOLOGICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. OSTEOBIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. OSTEOBIOLOGICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL OSTEOBIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. OSTEOBIOLOGICS MARKET DYNAMICS
  • TABLE 7. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY BONE MARROW ASPIRATE CONCENTRATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENIC PROTEIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PLASMA-RICH PROTEIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC ORTHOBIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY VISCO-SUPPLEMENTATION PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY BIOCERAMICS & COMPOSITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY INJECTABLE BIOMATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY ORTHOPEDIC BIOMATERIAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY MINERALIZED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY OSTEOCONDUCTIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY OSTEOINDUCTIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY BONE INFECTION & TUMORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY DENTAL BONE GRAFTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY TRAUMA & NON-UNION FRACTURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 110. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 116. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 122. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 127. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 128. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 139. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 140. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 145. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 146. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 151. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 152. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 164. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 165. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 170. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 171. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 176. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 177. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 182. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 183. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 188. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 189. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 194. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 195. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 200. ITALY OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 201. ITALY OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. ITALY OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 206. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 212. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 213. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 218. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 219. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 224. POLAND OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 225. POLAND OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. POLAND OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 230. QATAR OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 231. QATAR OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. QATAR OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 236. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 237. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 242. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 254. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 255. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 260. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 261. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 262. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 266. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 272. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 273. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 274. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY PROCESSING METHOD, 2018-2030 (USD MILLION)
  • TABLE 284. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY MATERIAL SOURCED, 2018-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 286. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 287. OSTEOBIOLOGICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 288. OSTEOBIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2023